Fractyl Health (GUTS) Liabilities and Shareholders Equity (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $99.4 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 19.68% year-over-year to $99.4 million; the trailing twelve-month figure through Mar 2026 stood at $397.1 million (down 14.51% YoY), and the FY2025 full-year result was $121.4 million, up 12.33% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $99.4 million, down from $121.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $163.5 million in Q1 2024 and bottomed at $62.0 million in Q2 2025.
• A 4-year average of $110.1 million and a median of $111.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity surged 41.81% in 2024 and tumbled 57.66% in 2025, its largest moves.
• Tracing GUTS's Liabilities and Shareholders Equity over 4 years: stood at $76.2 million in 2023, then surged by 41.81% to $108.1 million in 2024, then gained by 12.33% to $121.4 million in 2025, then decreased by 18.14% to $99.4 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $99.4 million, $121.4 million, and $114.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison